MX2019002017A - Derivados de sofosbuvir para el tratamiento de la hepatitis c. - Google Patents

Derivados de sofosbuvir para el tratamiento de la hepatitis c.

Info

Publication number
MX2019002017A
MX2019002017A MX2019002017A MX2019002017A MX2019002017A MX 2019002017 A MX2019002017 A MX 2019002017A MX 2019002017 A MX2019002017 A MX 2019002017A MX 2019002017 A MX2019002017 A MX 2019002017A MX 2019002017 A MX2019002017 A MX 2019002017A
Authority
MX
Mexico
Prior art keywords
hepatitis
treatment
sofosbuvir
derivatives
relates
Prior art date
Application number
MX2019002017A
Other languages
English (en)
Inventor
Moore George
Papp Michael
SCHOENE Olga
Wilhelm Thorsten
Lengauer Hannes
Strych Desiree
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of MX2019002017A publication Critical patent/MX2019002017A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/02—Phosphorylation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

La presente invención se refiere a novedosos compuestos para el tratamiento de la hepatitis C.
MX2019002017A 2016-08-19 2017-08-17 Derivados de sofosbuvir para el tratamiento de la hepatitis c. MX2019002017A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16184953 2016-08-19
PCT/EP2017/070832 WO2018033593A1 (en) 2016-08-19 2017-08-17 Sofosbuvir derivatives for the treatment of hepatitis c

Publications (1)

Publication Number Publication Date
MX2019002017A true MX2019002017A (es) 2019-06-06

Family

ID=56787311

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019002017A MX2019002017A (es) 2016-08-19 2017-08-17 Derivados de sofosbuvir para el tratamiento de la hepatitis c.

Country Status (7)

Country Link
US (1) US20190185507A1 (es)
EP (1) EP3500584A1 (es)
CN (1) CN109843900A (es)
AU (1) AU2017314148A1 (es)
CA (1) CA3033858A1 (es)
MX (1) MX2019002017A (es)
WO (1) WO2018033593A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110950919B (zh) * 2019-12-06 2021-06-04 南京正济医药研究有限公司 一种索非布韦的合成方法
CN111467363A (zh) * 2020-04-07 2020-07-31 中国科学院深圳先进技术研究院 索非布韦在制备预防和治疗冠状病毒的药物中的应用
CN111393494A (zh) * 2020-04-17 2020-07-10 广东帕派恩生物科技有限公司 基于核苷酸结构的化合物、制备方法、用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9821058D0 (en) * 1998-09-28 1998-11-18 Univ Cardiff Chemical compound
US7964580B2 (en) * 2007-03-30 2011-06-21 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs
TWI576352B (zh) 2009-05-20 2017-04-01 基利法瑪席特有限責任公司 核苷磷醯胺
CN102686599B (zh) * 2009-09-29 2016-10-05 杨森产品有限公司 核苷的氨基磷酸酯衍生物
EP2752422B1 (en) 2010-03-31 2017-08-16 Gilead Pharmasset LLC Stereoselective synthesis of phosphorus containing actives
CA2856529C (en) 2011-11-29 2018-03-06 Gilead Pharmasset Llc Compositions and methods for treating hepatitis c virus
US20130143835A1 (en) * 2011-12-05 2013-06-06 Medivir Ab HCV Polymerase Inhibitors
RU2534613C2 (ru) * 2013-03-22 2014-11-27 Александр Васильевич Иващенко Алкил 2-{ [(2r,3s,5r)-5-(4-амино-2-оксо-2н-пиримидин-1-ил)- -гидрокси-тетрагидро-фуран-2-илметокси]-фенокси-фосфориламино} -пропионаты, нуклеозидные ингибиторы рнк-полимеразы hcv ns5b, способы их получения и применения
UA117375C2 (uk) * 2013-09-04 2018-07-25 Медівір Аб Інгібітори полімерази hcv
TW201609785A (zh) 2013-12-23 2016-03-16 吉李德製藥公司 固體型之抗病毒化合物
CN104327137A (zh) * 2014-11-07 2015-02-04 王彩琴 一种氘代索菲布韦及其用途

Also Published As

Publication number Publication date
CA3033858A1 (en) 2018-02-22
WO2018033593A1 (en) 2018-02-22
US20190185507A1 (en) 2019-06-20
AU2017314148A1 (en) 2019-02-28
CN109843900A (zh) 2019-06-04
EP3500584A1 (en) 2019-06-26

Similar Documents

Publication Publication Date Title
ZA201906111B (en) Cyclic di-nucleotides compounds for the treatment of cancer
PH12016501192B1 (en) Tetrahydropyridopyrazines modulators of gpr6
EA201792205A1 (ru) Гетероциклические соединения как ингибиторы lsd1
EA202092609A1 (ru) Антитела к cd38 для лечения острого миелолейкоза
MX2020001278A (es) Sintesis de compuestos de carbamoilpiridona policiclica.
EA201891251A1 (ru) Бициклические ингибиторы pad4
MX2020006237A (es) Compuestos para el tratamiento de enfermedades relacionadas con la expresion de dux4.
PH12017500459A1 (en) Azetidinyloxyphenylpyrrolidine compounds
PH12016501941A1 (en) Use of heterocyclic compounds for controlling nematodes
MY180844A (en) Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
TW201613934A (en) Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
PH12016501613A1 (en) Pyrazines modulators of gpr6
IN2015CH01182A (es)
SG10201908248PA (en) Processes for preparing fluoroketolides
MX2019004182A (es) Proceso para la fabricacion de 2,6-dimetil-5-hepten-1-al.
MX2019002017A (es) Derivados de sofosbuvir para el tratamiento de la hepatitis c.
MX2018011877A (es) Proceso mejorado para la preparacion de tartrato de butorfanol.
MX2019008375A (es) Tiobenzoimidazol como fungicidas.
MX2018003903A (es) Compuesto biciclico y uso del mismo para inhibicion de suv39h2.
GB2564185A (en) Process for the preparation of derivatives of benzodioxole
PH12017501147A1 (en) Total synthesis of trioxacarcin dc-45-a2 and preparation of trioxacarcin analogs
IN2014MU00069A (es)
MX2017005669A (es) Derivados de hidroxido de bencilo, preparacion de los mismos y uso terapeutico de los mismos.
TR201401763A2 (tr) Sarkopeni'nin tedavisine yönelik bir kompozisyon.
IN2013MU01524A (es)